MAM
CERE

Melqart Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Melqart Asset Management’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,099,229
Closed -$44.9M – 63
2024
Q2 		$44.9M Buy
1,099,229
+154,865
+16% +$6.33M 3.72% 8
2024
Q1 		$39.9M Buy
944,364
+657,971
+230% +$27.8M 2.49% 11
2023
Q4 		$12.1M Buy
+286,393
New +$12.1M 0.89% 31